Showing results (1431-1440 of 1,451) with videos related to
Sort By:
Pageof 146
The Lancet. Oncology|January 17, 2022
Sugemalimab versus placebo after concurrent or sequential chemoradiotherapy in patients with locally advanced, unresectable, stage III non-small-cell lung cancer in China (GEMSTONE-301): interim results of a randomised, double-blind, multicentre, phase 3 trialQing Zhou, Ming Chen, Ou Jiang, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 10, 2025
First-Line Camrelizumab Versus Placebo Plus Chemotherapy With or Without Radiotherapy for Brain Metastases in NSCLC: The CTONG 2003 Randomized Placebo-Controlled TrialYang-Si Li, Qitao Yu, Qing Bu, et al.Cancer Biology & Medicine|September 7, 2021
Improved diagnosis of thyroid cancer aided with deep learning applied to sonographic text reports: a retrospective, multi-cohort, diagnostic studyQiang Zhang, Sheng Zhang, Jianxin Li, et al.JAMA Oncology|June 13, 2024
Circulating Tumor DNA-Guided De-Escalation Targeted Therapy for Advanced Non-Small Cell Lung Cancer: A Nonrandomized Controlled TrialSong Dong, Zhen Wang, Jia-Tao Zhang, et al.Iscience|August 31, 2021
A randomized trial of icosapent ethyl in ambulatory patients with COVID-19Andrew Kosmopoulos, Deepak L Bhatt, Gus Meglis, et al.Medicine|June 15, 2021
Multicenter analysis and a rapid screening model to predict early novel coronavirus pneumonia using a random forest algorithmSuxia Bao, Hong-Yi Pan, Wei Zheng, et al.Cancer Cell|October 10, 2023
Dynamic circulating tumor DNA during chemoradiotherapy predicts clinical outcomes for locally advanced non-small cell lung cancer patientsYi Pan, Jia-Tao Zhang, Xuan Gao, et al.Cell Reports|August 8, 2024
Lipid-associated macrophages for osimertinib resistance and leptomeningeal metastases in NSCLCYang-Si Li, Wen-Pu Lai, Kai Yin, et al.Journal for Immunotherapy of Cancer|November 28, 2025
Cellular dynamics in cerebrospinal fluid unveils the key regulators of intracranial response to immune checkpoint inhibitors in NSCLC brain metastasesYang-Si Li, Wenpu Lai, Kai Yin, et al.Nature Medicine|February 27, 2025
Cerebrospinal fluid circulating tumor DNA profiling for risk stratification and matched treatment of central nervous system metastasesMei-Mei Zheng, Qing Zhou, Hua-Jun Chen, et al.Pageof 146